HLB Pharmaceutical Co., Ltd (047920.KQ)

KRW 23050.0

(-1.5%)

Total Debt Summary of HLB Pharmaceutical Co., Ltd

  • HLB Pharmaceutical Co., Ltd's latest annual total debt in 2023 was 23.72 Billion KRW , down -9.96% from previous year.
  • HLB Pharmaceutical Co., Ltd's latest quarterly total debt in 2024 Q2 was 16.55 Billion KRW , down -2.59% from previous quarter.
  • HLB Pharmaceutical Co., Ltd reported annual total debt of 26.35 Billion KRW in 2022, down -20.16% from previous year.
  • HLB Pharmaceutical Co., Ltd reported annual total debt of 33 Billion KRW in 2021, down -18.0% from previous year.
  • HLB Pharmaceutical Co., Ltd reported quarterly total debt of 16.99 Billion KRW for 2024 Q1, down -28.36% from previous quarter.
  • HLB Pharmaceutical Co., Ltd reported quarterly total debt of 23.29 Billion KRW for 2023 Q2, down -8.16% from previous quarter.

Annual Total Debt Chart of HLB Pharmaceutical Co., Ltd (2023 - 2016)

Historical Annual Total Debt of HLB Pharmaceutical Co., Ltd (2023 - 2016)

Year Total Debt Total Debt Growth
2023 23.72 Billion KRW -9.96%
2022 26.35 Billion KRW -20.16%
2021 33 Billion KRW -18.0%
2020 40.25 Billion KRW 204.97%
2019 13.19 Billion KRW 71.54%
2018 7.69 Billion KRW -48.55%
2017 14.95 Billion KRW -1.28%
2016 15.14 Billion KRW 0.0%

Peer Total Debt Comparison of HLB Pharmaceutical Co., Ltd

Name Total Debt Total Debt Difference
CMG Pharmaceutical Co., Ltd. 19.74 Billion KRW -20.181%
Celltrion Pharm, Inc. 162.52 Billion KRW 85.401%
Huons Global Co., Ltd. 254.93 Billion KRW 90.693%
DongKook Pharmaceutical Co., Ltd. 104.74 Billion KRW 77.348%
Enzychem Lifesciences Corporation 5.65 Billion KRW -319.44%
Humedix Co., Ltd. 2.7 Billion KRW -778.236%
Boditech Med Inc. 10.56 Billion KRW -124.527%
EuBiologics Co., Ltd. 14.77 Billion KRW -60.553%
FutureChem Co.,Ltd 3.68 Billion KRW -544.33%
Huons Co., Ltd. 124.61 Billion KRW 80.959%
BNC Korea Co., Ltd. 737.2 Million KRW -3118.599%
AptaBio Therapeutics Inc. 13.93 Billion KRW -70.286%